QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
NYSE:HAE

Haemonetics - HAE Price Target & Analyst Ratings

$84.60
+0.36 (+0.43%)
(As of 01/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$83.04
$85.05
50-Day Range
$72.75
$90.60
52-Week Range
$44.98
$91.39
Volume
440,892 shs
Average Volume
489,139 shs
Market Capitalization
$4.28 billion
P/E Ratio
50.96
Dividend Yield
N/A
Price Target
$97.50

Haemonetics Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 6 Analyst Ratings

Consensus Analyst Price Target

$97.50
15.25% Upside
High Prediction$110.00
Average Prediction$97.50
Low Prediction$84.00
TypeCurrent
1/31/22 to 1/31/23
1 Month Ago
1/1/22 to 1/1/23
3 Months Ago
11/2/21 to 11/2/22
1 Year Ago
1/31/21 to 1/31/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
5 Buy rating(s)
Hold
2 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$97.50$96.83$86.83$73.00
Predicted Upside15.25% Upside16.67% Upside19.30% Upside30.90% Upside
Get Haemonetics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter.


HAE Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HAE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Haemonetics Stock vs. The Competition

TypeHaemoneticsMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.65
2.46
Consensus RatingModerate BuyBuyHold
Predicted Upside15.25% Upside1,063.96% Upside9.16% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/24/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$100.00 ➝ $110.00+22.39%
1/6/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$90.00 ➝ $84.00+10.80%
12/12/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$88.00 ➝ $92.00+14.80%
11/8/2022Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$88.00 ➝ $94.00+12.48%
11/8/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$88.00 ➝ $100.00+19.66%
11/8/2022JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Turkaly
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetMarket Outperform$90.00 ➝ $105.00+25.64%
1/27/2022Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
5/14/2021Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$105.00 ➝ $85.00+64.06%
5/14/2021CJS Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform
(Data available from 1/31/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












HAE Price Target - Frequently Asked Questions

What is Haemonetics's consensus rating and price target?

According to the issued ratings of 6 analysts in the last year, the consensus rating for Haemonetics stock is Moderate Buy based on the current 2 hold ratings and 4 buy ratings for HAE. The average twelve-month price prediction for Haemonetics is $97.50 with a high price target of $110.00 and a low price target of $84.00. Learn more on HAE's analyst rating history.

Do Wall Street analysts like Haemonetics more than its competitors?

Analysts like Haemonetics more than other Medical companies. The consensus rating for Haemonetics is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how HAE compares to other companies.

Does Haemonetics's stock price have much upside?

According to analysts, Haemonetics's stock has a predicted upside of 17.82% based on their 12-month price targets.

What analysts cover Haemonetics?

Haemonetics has been rated by Barrington Research, Citigroup, JMP Securities, Mizuho, Morgan Stanley, and Raymond James in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:HAE) was last updated on 1/31/2023 by MarketBeat.com Staff